maría de luna, 11 – nave 13
+34 976 512 887
AlphaSIP is a Spanish SME, whose mission is to become a leader in the Point of Care and Medical Device markets, with main applications around Human Diagnostics and screening. AlphaSIP’s activities aim to enhance personalized treatment and safety, focusing on the development and commercialization of proprietary technology.
AlphaSIP currently commercializes DrugSIP and DrugSIP mobility, a PoC devices for detecting drugs of abuse in saliva or urine. Amongst the products in development, AlphaSIP presents PneumoSIP, a sample-to-result (qPCR) diagnostics device, winner of the H2020 SME Instrument. Its first indication for pneumonia aims to detect the main aetiologies and antibiotic resistances for fast and guided treatment. AlphaSIP’s new DrugSIP, featuring improved reading capabilities and wider test range, completes our offer for the healthcare market. Both devices also are a open platforms for lateral flow/rapid test and qPCR detections.
AlphaSIP is looking for industrial partners and distributors for its products in European markets